Funds focus on emerging markets

Investors expect private equity funds focusing on emerging markets to outperform those investing in advanced economies in coming years, according to a global survey from the Emerging Markets Private Equity Association (EMPEA) today. A total of 77% of private equity investors surveyed said they believe annual returns from their developing-country portfolio will reach at least […]

Tembusu Partners successfully sells its 2.2% stake in Van Der Horst Energy

Tembusu Partners announces today that it has successfully divested its investment in Van Der Horst Energy for approximately S$ 2m. Tembusu Partners invested about S$ 1m into Van Der Horst Biodiesel in April 2007, which was subsequently acquired by GKE International Limited, “GKE”. GKE was subsequently renamed to Van Der Horst Energy. Following the acquisition, […]

Singapore-Nanjing venture sets up US$100m fund

Tembusu Partners will be setting up a fund management company in cooperation with Nanjing Hi-Tech Venture Capital Co and Venture Capital and Consulting to manage $USD100 million Nanjing Growth Fund to invest in fast-growing companies in China.

Acquisition of Jiayi International Holdings Limited

On 4 March 2008, we invested in Jiayi International Holdings Limited via a convertible loan to secure a stake in the Fujian, China-based company. JIAYI is principally engaged in global sourcing and supply chain management for sports footwear and apparel; its is also a significant player in manufacturing of sports footwear for OEM customers, including […]

Acquisition of Tangshan Ganglu Iron & Steel Co. Ltd

On 26 February, 2008, we acquired a stake in Tangshan Ganglu Iron & Steel Company. Based in Zhunhua city of Hebei province, China, Ganglu is an integrated iron and steelmaker for a wide range of hot-rolled steel products. Currently, Ganglu is ranked among China’s Top 500 Enterprises, with ISO9001 certification.

Acquisition of China Dredging & Engineering Pte Ltd

On 23 November 2007, we invested in China Dredging & Engineering Pte Ltd. The key thurst of this investment is to seize the opportunities presented by Tianjin’s marine redevelopments. The Company currently operates two dredges, servicing Tianjin harbor’s dredging and land reclamation projects.

Acquisition of Ying Tai Bio-Technology Pte Ltd – Yingtai

On the 23rd November 2007, we signed an agreement to invest in Ying Tai Bio-Technology Pte Ltd, “Yingtai”. Yingtai is involved in the production of a biological enzyme, Lysostaphin, which is a substitute for antibiotics. Two of their product ranges currently available for sale are Xinjingjie (OTC segment) and Baikerui (hospital segment).

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.